Summarized & reviewed by The Peptide Dispatch Editorial Team · Last reviewed July 3, 2026
Your Cells Are Running Out of Fuel — And No Standard Blood Panel Is Checking The NAD+ collapse nobody told you about You hit 45 and the wheels start coming off. Afternoon fatigue you can't caffeine your way out of. Workouts that used to leave you sharp now leave you flat. Recovery takes days instead of hours. Your labs come back "normal." Your doctor shrugs and tells you it's just age. It is age…
This dispatch covers Your Cells Are Running Out of Fuel — And No Standard Blood Panel Is Checking in the research research category, authored by The Peptide Dispatch Editorial Team. Estimated reading time: 10 minutes. The Peptide Dispatch curates peer-reviewed peptide research for self-directed learners. All summaries are presented for Research Use Only and do not constitute medical advice.
You hit 45 and the wheels start coming off.
Afternoon fatigue you can't caffeine your way out of. Workouts that used to leave you sharp now leave you flat. Recovery takes days instead of hours. Your labs come back "normal." Your doctor shrugs and tells you it's just age.
It is age — but not in the way they're framing it. Research suggests the core issue is metabolic, not chronological. By the time most professionals reach their mid-40s, cellular levels of NAD+ (nicotinamide adenine dinucleotide) have dropped roughly 50% from their early-20s peak. NAD+ is the molecule that turns food into usable energy inside your mitochondria. When it falls, everything downstream falls with it — strength, focus, insulin sensitivity, recovery, resilience.
No annual physical tests for it. No standard metabolic panel flags it. And it's one of the most-studied aging mechanisms in longevity medicine right now.
Every cell in your body contains mitochondria — tiny power plants that convert glucose, fat, and amino acids into ATP, the energy currency that runs muscle contraction, brain signaling, immune function, hormone synthesis, and tissue repair.
NAD+ is the electron shuttle those power plants depend on. Without enough of it:
According to PubMed, a 2025 comprehensive review published in npj Metabolic Health and Disease concluded that declining NAD+ levels are "associated with general aging and chronic disorders, including cognitive decline, sarcopenia, and metabolic diseases" — and that NAD+ loss disrupts mitochondrial homeostasis through failure of mitophagy, the unfolded protein response, and antioxidant defense (DOI).
Translation: when your NAD+ tank runs low, your cells lose the ability to clean up damaged mitochondria, manage oxidative stress, or recover from daily wear. You don't feel "a little off." You feel cooked.
The NAD+ decline curve is steeper for people who live the way successful professionals live. The drivers aren't mysterious. They're just never measured.
Chronic stress and cortisol exposure. Activated PARP enzymes (triggered by inflammation, poor sleep, and metabolic stress) consume NAD+ faster than baseline metabolism uses it. High-cortisol lifestyles burn through NAD+ reserves.
Alcohol. Ethanol metabolism is NAD+-dependent. Every glass of wine, every business dinner cocktail — you're paying a direct NAD+ tax. Heavy weekly drinkers run depleted.
Visceral fat and insulin resistance. Obesity and metabolic dysfunction upregulate an enzyme called CD38, which degrades NAD+ inside cells. A 2024 Nature Aging paper demonstrated that aberrant CD38 upregulation during aging is a primary driver of NAD+ metabolic dysfunction and mitochondrial stress (DOI). More belly fat, more CD38, less NAD+. It's a closed loop.
Sleep deprivation. The mitochondrial repair cycle happens overnight. Six hours or less, chronically, and the system never catches up.
Over-training without recovery. High-volume exercise on depleted NAD+ accelerates oxidative damage rather than driving adaptation.
This is why a 48-year-old founder who sleeps 6 hours, drinks four nights a week, pushes through CrossFit three times a week, and carries 20 extra pounds around the middle feels 15 years older than a matched peer who doesn't. The chronological age is the same. The NAD+ status isn't.
The scientific literature on boosting NAD+ in adults is no longer theoretical. It's clinical.
The Yoshino/Klein trial (2021, Science). A randomized, placebo-controlled, double-blind study of NMN (nicotinamide mononucleotide, an NAD+ precursor) in postmenopausal women with prediabetes. After 10 weeks, the NMN group showed significant improvements in muscle insulin sensitivity, AKT/mTOR signaling, and expression of genes related to muscle remodeling. The placebo group did not change (DOI).
2025 systematic review and meta-analysis. Published in Current Pharmaceutical Biotechnology, pooling 412 participants across 9 RCTs. NMN supplementation in middle-aged and elderly adults produced significant improvements in gait speed (muscle function proxy), HOMA-IR (insulin resistance), and ALT (liver function). The authors concluded NMN "has positive efficacy in enhancing muscle function, reducing insulin resistance and lowering aminotransferase levels" (DOI).
Trigonelline research (2024, Nature Metabolism). Researchers identified trigonelline — a compound in coffee and fenugreek — as a natural NAD+ precursor. In humans, serum trigonelline levels correlate positively with muscle strength and skeletal muscle mitochondrial oxidative phosphorylation, and are reduced in sarcopenia. Supplementation increased NAD+ in primary myotubes from both healthy individuals and individuals with sarcopenia (DOI).
Studies show NAD+ decline is measurable, reversible in part through precursors, and meaningfully tied to the three things executives care most about: muscle, insulin sensitivity, and metabolic function.
Conventional primary care has no framework for NAD+ decline. The visit goes like this:
Nothing tested your mitochondrial function. Nothing assessed your NAD+ trajectory. Nothing measured the downstream markers — insulin, ApoB, homocysteine, lactate, cortisol, hs-CRP — that together paint a picture of cellular energy capacity. The entire conversation assumed your complaints were psychological because the conventional panel doesn't ask the right questions.
This is the same pattern we've covered in prior Dispatch articles on insulin resistance, cortisol, and the 2026 cholesterol guidelines. The standard annual physical checks roughly 5 things. Your cellular metabolism involves 80+ moving parts.
You don't directly measure NAD+ on a routine basis — the assay is expensive, unstable in standard blood draws, and of limited clinical utility in isolation. What you can measure, and what actually informs a protocol, are the downstream fingerprints of NAD+ and mitochondrial decline:
| Marker | What it tells you | Standard panel? |
|---|---|---|
| Fasting insulin | Mitochondrial glucose handling | No |
| HOMA-IR | Cellular insulin resistance | No |
| HbA1c + fasting glucose together | Glycemic trajectory vs. snapshot | Partial |
| ApoB / LDL-P | Metabolic inflammation proxy | No |
| hs-CRP | Systemic inflammation burden | Rarely |
| Homocysteine | Methylation + B-vitamin status | No |
| Lactate (at rest or post-exercise) | Mitochondrial oxidative capacity | No |
| Free and total testosterone | Anabolic capacity, recovery | Partial |
| DHEA-S, cortisol (AM/PM) | Adrenal reserve and stress burn | No |
| Vitamin B3, B6, B12, folate | NAD+ precursor availability | No |
| Ferritin | Cellular iron status, mitochondrial enzyme cofactor | No |
| Magnesium RBC | 300+ mitochondrial reactions | No |
Research suggests when these markers move together in a specific pattern — elevated fasting insulin, climbing ApoB, rising hs-CRP, falling testosterone, low B-vitamin status, low ferritin — the underlying story is often mitochondrial efficiency loss driven by NAD+ depletion. None of it shows up on a CBC.
Before any talk of compounded therapies or exotic supplements, research suggests the highest-leverage NAD+ interventions are behavioral. The supplement conversation is downstream.
1. Protect sleep first. Mitochondrial biogenesis and mitophagy happen in deep sleep. Seven to eight hours, consistent bedtime, dark cold room. This is non-negotiable for NAD+ recovery. Studies show chronic short sleep measurably suppresses mitochondrial function.
2. Drop visceral fat. Every inch off the waistline reduces CD38 activity and slows NAD+ degradation. Research suggests waist-to-height ratio under 0.5 is the target. Waist > half your height is the metabolic red line.
3. Resistance train three days a week. Not CrossFit. Progressive overload, compound movements, adequate recovery. Skeletal muscle is the single largest mitochondrial reservoir in the body. More muscle = more mitochondria = more NAD+ capacity.
4. Cut drinks per week. Alcohol is the fastest way to drain NAD+ you control. Two drinks per week is a different metabolic world than two drinks per night.
5. Dietary precursors. Niacin (B3) in food form — organ meats, poultry, fish, peanuts, mushrooms. Trigonelline in coffee (yes, your morning coffee has real biological value). Tryptophan-rich protein for the de novo NAD+ pathway.
6. Consider targeted precursors if the data supports it. NMN and NR (nicotinamide riboside) are the two most-studied precursors. The 2025 meta-analysis suggests clinical benefit at typical doses in middle-aged adults. This is not a standalone fix — it's an amplifier for the first five items. Supplement in a vacuum of bad sleep, heavy drinking, and visceral fat is lighter fluid on damp wood.
Our Precision Diagnostic runs 80 biomarkers across 12 health domains — including the full fingerprint of mitochondrial and NAD+ metabolism outlined above. B-vitamins, methylation markers, inflammation, insulin, cortisol rhythm, hormone status, and body composition (including waist-to-height ratio) all feed into one composite picture.
Our Protocol Engine runs 35 clinical decision rules against those 123 markers to identify where your cellular energy system is failing first — and what ordered sequence of interventions gives the fastest recovery. The output is a personalized plan, not a generic "take NMN and see what happens."
If you're in your 40s or 50s, performing at a high level, and feel like the engine is losing efficiency despite doing "everything right" — the engine probably is losing efficiency. And it's measurable.
Start here: Precision Diagnostic — $599 (123 markers + biological age + 1:1 NP consultation)
Or if you already have recent labs and want a full protocol analysis: Protocol Engine — $299.
Citations: PubMed via biomedical research tools.
The Peptide Dispatch is educational. Nothing here is medical advice, a diagnosis, or a treatment recommendation. Work with a qualified clinician before starting any supplement or therapy.
Educational content — not medical advice. Effects described are drawn from cited research in study subjects.